# Dianthus Therapeutics, Inc.: Form SC 13D, filed Jul 14, 2020

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: SC 13D
- Filed: 2020-07-14
- Accepted by EDGAR: Jul 14, 2020, 16:34 ET
- Period: not reported
- Accession: 0001387131-20-006396
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000138713120006396/magenta-sc13d_062920.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000138713120006396/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000138713120006396/magenta-sc13d_062920.htm

Filed Jul 14, 2020.
Source: SEC EDGAR, the filing index for accession 0001387131-20-006396. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.